DexCom (NASDAQ: DXCM) reported Q4 EPS of $0.10, $0.07 better than the analyst estimate of $0.03. Revenue for the quarter came in at $221 million versus the consensus estimate of $215.87 million.

For earnings history and earnings-related data on DexCom (DXCM) click here.